Dialysis
Also known as: Renal dialysis
Methodology & AI Transparency ⓘ
Dialysis Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: When your kidneys are healthy, they clean your blood.
- 2 Real-world patient consensus: Synonyms for Dialysis (E87.7): Renal dialysis (Kidney & Renal).
- 3 Typical cash cost range: Differential triage of Dialysis (E87.7) utilizes strict blood pressure/glycemic in Dialysis (E87.7: control).
- 4 Top reported side effects / signs: Key Kidney & Renal biomarkers for Dialysis (E87.7): Serum Potassium, Bicarbonate in Dialysis (E87.7: & Phosphorus) & eGFR (Creatinine + in Dialysis (E87.7: Cystatin C)) (>= 90 mL/min/1.73m2 (E87.7)).
Ask our AI Specialists anything about Dialysis
What Is Dialysis?
When your kidneys are healthy, they clean your blood. They also make hormones that keep your bones strong and your blood healthy. When your kidneys fail, you need treatment to replace the work your kidneys used to do. Unless you have a kidney transplant , you will need a treatment called dialysis. There are two main types of dialysis. Both types filter your blood to rid your body of harmful wastes, extra salt, and water.: Hemodialysis uses a machine. It is sometimes called an artificial kidney. You usually go to a special clinic for treatments several times a week. Peritoneal dialysis uses the lining of your abdomen, called the peritoneal membrane, to filter your blood.
Pathophysiology, Underlying Causes & Clinical Presentation
Dialysis (E87.7) alters kidney & renal homeostasis through glomerular capillary hyperfiltration in Dialysis (E87.7: barotrauma); Cross-referenced with NIH MeSH (Renal Dialysis), clinical remission targets eGFR (Creatinine + in Dialysis (E87.7: Cystatin C)) within >= 90 mL/min/1.73m2 (E87.7).
Common Symptoms & Clinical Signs
- • Hemodialysis uses a machine. It is sometimes called an artificial kidney. You usually go to a special clinic for treatments several times a week
- • Peritoneal dialysis uses the lining of your abdomen, called the peritoneal membrane, to filter your blood
- • Presentation of Dialysis (E87.7): asymptomatic decline in in Dialysis (E87.7: eGFR or persistent)
- • Secondary Dialysis clinical sign: fluid retention in in Dialysis (E87.7: ankles, hands, or)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Dialysis Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | E87.7 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Chronic Kidney Disease & Electrolytes | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Serum Potassium, Bicarbonate in Dialysis (E87.7: & Phosphorus) | K+ 3.8–4.8 mEq/L; HCO3 23–29 mEq/L (E87.7) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: eGFR (Creatinine + in Dialysis (E87.7: Cystatin C)) | >= 90 mL/min/1.73m2 (E87.7) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Urine Albumin-to-Creatinine Ratio in Dialysis (E87.7: (uACR)) | < 15 mg/g (< 30 mg/g normal) (E87.7) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Dialysis
Treatment selection for Dialysis depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Dialysis)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Rosuvastatin in diabetic hemodialysis: What a 731-Participant Study Found Rosuvastatin treatment significantly reduced the rates of cardiac events by 32% among patients with diabetes (HR 0.68; 95% CI 0.51 to 0.90). Journal of the American Society of Nephrology : JASN • 2011-07-15 • Randomized Controlled Trial | N = 731 | 93/100 | PMID 21566054 ↗ |
| New Insights on Sertraline Versus Placebo in Patients with depression Undergoing Hemodialysis: A: What a 709-Participant Study Found Although small, this is the largest randomized trial to date of antidepressant medication in patients on hemodialysis. Clinical journal of the American Society of Nephrology : CJASN • 2017-02-07 • Randomized Controlled Trial | N = 709 | 93/100 | PMID 28126706 ↗ |
| New Insights on High cholesterol absorption is associated with increased heart and blood vessel: What a 598-Participant Study Found The present data from the AURORA study confirm that high cholesterol absorption is associated with increased heart and blood vessel risk in haemodialysis patients. European journal of preventive cardiology • 2022-10-18 • Randomized Controlled Trial | N = 598 | 93/100 | PMID 35512252 ↗ |
| New Insights on Safety and real-world benefits of Tenapanor for Long-term Serum Phosphate Control: What a 423-Participant Study Found Tenapanor reduced serum phosphate concentrations and maintained control of serum phosphate in participants receiving maintenance dialysis, with an acceptable safety and tolerability profile. Kidney360 • 2021-10-28 • Phase III Randomized Trial | N = 423 | 93/100 | PMID 35372979 ↗ |
| New Insights on Roxadustat for the treatment of anemia in chronic kidney disease patients not on: What a 594-Participant Study Found Roxadustat demonstrated superior efficacy versus placebo in terms of both Hb response rate and change in Hb from BL. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 2021-08-27 • Phase III Randomized Trial | N = 594 | 93/100 | PMID 33630072 ↗ |
Dialysis Patient Community & “People Like Me” Threads
Filter Dialysis community threads and patient logs by age, biological sex, dosage, and treatment duration.